top of page

Aries Biotech Consults for Montine Lab at Stanford University

Neurological Disease and Dementia Strategies

Aries Biotech and the Montine Lab, at Stanford University, are merging their expertise in neurological disease progression and mitigation strategies. Led by Dr. Tom Montine, M.D., PhD, the Montine Lab focuses on the structural and molecular bases of cognitive impairment and dementia through assessment of neuropathology, biomarkers, and pharmacology. Aries Biotech is a neurological disease and dementia biomarker consulting company that provides guidance, data interpretation, and document review for hypothesis-driven research.

Additional information about the Montine Lab may be found at

To learn how we can augment your research and development,

visit Aries Biotech at

Services are also now available through the university vendor portal.

10 views0 comments

Recent Posts

See All

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

bottom of page